Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acumen Pharmaceuticals
Biotech
Acumen taps JCR’s brain barrier tech for $555M Alzheimer’s deal
The collaboration will involve pairing JCR’s J-Brain Cargo platform with Acumen’s amyloid beta oligomer-selective antibodies.
James Waldron
Jul 15, 2025 8:01am
Trevena teeters on edge with C-suite shakedown—Chutes & Ladders
Nov 8, 2024 8:30am
Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders
Feb 2, 2024 9:30am
Acumen posts early Alzheimer's data for next-gen Leqembi rival
Jul 17, 2023 5:32am
Acumen surges in IPO debut, raises $160M for Alzheimer's drug
Jul 1, 2021 2:43pm
Acumen prices IPO, targets phase 2 data on amyloid-beta prospect
Jun 25, 2021 8:30am
